Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
BACKGROUND: Currently, population pharmacokinetic (PK) studies of anti-malarial drugs are designed primarily by the logistical and ethical constraints of taking blood samples from patients, and the statistical models that are fitted to the data are not formally considered. This could lead to impreci...
Hoofdauteurs: | Jamsen, K, Duffull, S, Tarning, J, Lindegardh, N, White, N, Simpson, J |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
BioMed Central
2011
|
Gelijkaardige items
-
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
door: Lindegardh Niklas, et al.
Gepubliceerd in: (2011-07-01) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria.
door: Jamsen, K, et al.
Gepubliceerd in: (2012) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
door: Jamsen Kris M, et al.
Gepubliceerd in: (2012-07-01) -
Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
door: Tarning, J, et al.
Gepubliceerd in: (2012) -
Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
door: Tarning, J, et al.
Gepubliceerd in: (2012)